” LumeNXT Appoints Marc Beer as Chairman of the Board “

 

Marc Beer, Founder and CEO of Renovia Inc., has been named by LumeNXT as the Chairman of its Board. LumeNXT is a leading company dedicated to the development of a proprietary surgical illumination solution for minimally invasive surgeries. He boasts more than 25 years of development as well as commercialization experience in devices, biotechnology, pharmaceuticals, as well as diagnostics.

 

According to Marc Beer, he is glad to be working with a committed and dedicated group of surgeons as well as engineers who have contributed a lot to the advancement of the field of surgical illumination including the LumeNXT proprietary technology which is playing a big role in safe performing of surgeries. As more surgeries are being carried out leveraging minimally invasive approaches, the importance of the platform will continue to suffice. Surgeons have testified to the efficiency of the technology and they have found that it enhances precision, visualization, as well as flexibility during surgical procedures as compared to traditional techniques.

 

LumeNXT’s advanced illumination platform serves as a heat reduction mechanism to enhance safety, low-cost disposable options, and surgical precision through enhanced visualization. According to Paul Rhyne, Co-Founder of LumeNXT, Marc Beer has achieved a lot in his career life establishing startup companies and helping them to grow. He has valuable experience in starting as well as guiding companies through global commercial rollout and lead them along the path to profitability.

 

Marc Beer founded Renovia Inc. with a mission to develop and provide innovative therapeutic and diagnostic devices to women affected by pelvic floor disorders. Formally, he was the founding chairman of Minerva Neurosciences Inc., a biopharmaceutical company which develops products to treat central nervous system diseases. The company performs multiple late-stage clinical trials and develops innovative therapeutic compounds for insomnia, schizophrenia, mood disorders, Parkinson’s disease, and major depressive disorders.

 

Previously, he held several leadership positions in the biopharmaceutical sector where he headed commercial launches addressing rare disease on a global growth, global scale, initial public offerings, acquisitions and many more. Marc Beer’s other previous positions include Founding Chairman of the board of Good Start Genetics, Inc., CEO of ViaCell, Erytech Pharma Board of Directors, Global Marketing Vice President at Genzyme, as well as other various sales and marketing positions at Abbot Laboratories. He served at the Mass Life Science Board of the Commonwealth of Massachusetts as a members. He also held a position at the Biotechnolgy Industry Organization (BIO) Emerging Companies Section Governing Board. Today, he serves as the Co-founder, chairman and CEO at Renovia Inc. He is a graduate from Miami University, Ohio. Recently, he successful closed $42 million in venture and debt for the women’s health startup. The money was used to develop and test four more new products. Learn more: https://renoviainc.com/